News

GPC dismisses speculation DDRB legal challenge will fail

30-Apr-08

Richard Vautrey
The GPC has dismissed rumours that its legal challenge to the Doctors' and Dentists' Review Body (DDRB) report has no chance of success.

Press reports last week said unnamed ‘ministerial sources' were claiming that the BMA had no case, and advising the government to stand firm.

But Dr Richard Vautrey, deputy GPC chairman, said: ‘We've not heard anything at all. If they are so confident it surprises me that they've not responded at all to our letter.'

A DoH spokesman said that the government was considering the challenge, and would respond in due course.

The BMA's challenge rests on paragraph 3.12 of the Statement of Fees and Entitlements, which claims that the monthly correction factor payments will increase at the same ‘uprating percentage' as the global sum payment.

GPC sources say that the DDRB ignored this statement. Instead it gave undue weight to the aspiration in paragraph 1.6 of the 2006/7 contract revisions, that practices should become less reliant on MPIG.

jonn.elledge@haymarket.com

Comment below and tell us what you think

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Healthcare Republic Forums

 

Registrar

Assessment guide is useful for all

Mock scenarios and helpful exercises make this book more than an exam guide, says Dr Lizzie Croton. Read more

Women's health - Terminate pregnancies

Requests for pregnancy termination should be handled with sensitivity, writes Dr Mona Kular. Read more

Clinical skills assessment

In the first of a regular look at the nMRCGP, Dr Daryl Goodwin explains how to pass the CSA. Read more

Show all articles

 

Latest Clinical Articles

Sjogren's syndrome

Contributed by Dr Jeffery Lee, consultant rheumatologist, Barnet Hospital, Hertfordshire. Read more

Chronic kidney disease

Section 1: Epidemiology and classification  Chronic kidney disease (CKD) encompasses abnor... Read more

Acute kidney injury

Contributed by Dr Stephan Brincat, specialist registrar, and Dr Rachel Hilton, consultant nephrologi... Read more

Show all clinical articles

MIMS Product News

New drug - Eucreas

Eucreas (vildagliptin + metformin) is a new fixed-dose combination treatment for patients inadequate... Read more

New drug - Galvus

Novartis has launched a new oral hypoglycaemic for the treatment type II diabetes. Read more

Coversyl formulation change

Coversyl and Coversyl Plus have been discontinued and replaced by Coversyl Arginine and Coversyl Arg... Read more

Jobs

 

Job of the Week